{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T08:39:13Z","timestamp":1788165553994,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,27]]},"DOI":"10.7759\/cureus.78057","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:59:52Z","timestamp":1737979192000},"source":"Crossref","is-referenced-by-count":3,"title":["Vasoplegic Syndrome Following Bypass: A Comprehensive Review of Pathophysiology and Proposed Treatments"],"prefix":"10.7759","author":[{"given":"Jaime P","family":"Torrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise A","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suely P","family":"Zeferino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana F","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ot\u00e1vio C","family":"Auler Jr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.15896","article-title":"Postoperative systemic inflammatory dysregulation and corticosteroids: a narrative review","volume":"78","author":"Bain CR","year":"2023","unstructured":"Bain CR, Myles PS, Corcoran T, Dieleman JM. Postoperative systemic inflammatory dysregulation and corticosteroids: a narrative review. Anaesthesia. 2023, 78:356-70. 10.1111\/anae.15896","journal-title":"Anaesthesia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s11748-017-0789-6","article-title":"Risk assessment and outcomes of vasoplegia after cardiac surgery","volume":"65","author":"Tsiouris A","year":"2017","unstructured":"Tsiouris A, Wilson L, Haddadin AS, Yun JJ, Mangi AA. Risk assessment and outcomes of vasoplegia after cardiac surgery. Gen Thorac Cardiovasc Surg. 2017, 65:557-65. 10.1007\/s11748-017-0789-6","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-020-2743-8","article-title":"Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options","volume":"24","author":"Busse LW","year":"2020","unstructured":"Busse LW, Barker N, Petersen C. Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options. Crit Care. 2020, 24:36. 10.1186\/s13054-020-2743-8","journal-title":"Crit Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0000000000000341","article-title":"Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment","volume":"349","author":"Omar S","year":"2015","unstructured":"Omar S, Zedan A, Nugent K. Cardiac vasoplegia syndrome: pathophysiology, risk factors and treatment. Am J Med Sci. 2015, 349:80-8. 10.1097\/MAJ.0000000000000341","journal-title":"Am J Med Sci"},{"key":"ref5","article-title":"The postperfusion syndrome: inflammation and the damaging effects of cardiopulmonary bypass","author":"Kirklin JK","year":"1989","unstructured":"Kirklin JK. The postperfusion syndrome: inflammation and the damaging effects of cardiopulmonary bypass. Cardiopulmonary Bypass: Current Concepts and Controversies. Tinker JH (ed): WB Saunders, Philadelphia (PA); 1989. 1989-131."},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-5223(94)70355-8","article-title":"Vasoplegic syndrome: a new dilemma","volume":"107","author":"Gomes WJ","year":"1994","unstructured":"Gomes WJ, Carvalho AC, Palma JH, Gon\u00e7alves I Jr, Buffolo E. Vasoplegic syndrome: a new dilemma. J Thorac Cardiovasc Surg. 1994, 107:942-3.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/jocs.15805","article-title":"Vasoplegic syndrome after cardiovascular surgery: a review of pathophysiology and outcome-oriented therapeutic management","volume":"36","author":"Datt V","year":"2021","unstructured":"Datt V, Wadhhwa R, Sharma V, Virmani S, Minhas HS, Malik S. Vasoplegic syndrome after cardiovascular surgery: a review of pathophysiology and outcome-oriented therapeutic management. J Card Surg. 2021, 36:3749-60. 10.1111\/jocs.15805","journal-title":"J Card Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivy352","article-title":"Risk factors for vasoplegia after cardiac surgery: a meta-analysis","volume":"28","author":"Dayan V","year":"2019","unstructured":"Dayan V, Cal R, Giangrossi F. Risk factors for vasoplegia after cardiac surgery: a meta-analysis. Interact Cardiovasc Thorac Surg. 2019, 28:838-44. 10.1093\/icvts\/ivy352","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(98)70049-2","article-title":"Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent","volume":"116","author":"Argenziano M","year":"1998","unstructured":"Argenziano M, Chen JM, Choudhri AF, et al.. Management of vasodilatory shock after cardiac surgery: identification of predisposing factors and use of a novel pressor agent. J Thorac Cardiovasc Surg. 1998, 116:973-80. 10.1016\/S0022-5223(98)70049-2","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/cc10516","article-title":"Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration","volume":"15","author":"Colson PH","year":"2011","unstructured":"Colson PH, Bernard C, Struck J, Morgenthaler NG, Albat B, Guillon G. Post cardiac surgery vasoplegia is associated with high preoperative copeptin plasma concentration. Crit Care. 2011, 15:R255. 10.1186\/cc10516","journal-title":"Crit Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/s0003-4975(01)02486-9","article-title":"Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function","volume":"71","author":"Mekontso-Dessap A","year":"2001","unstructured":"Mekontso-Dessap A, Ho\u00fcel RL, Soustelle C, Kirsch M, Th\u00e9bert D, Loisance DY. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg. 2001, 71:1428-32. 10.1016\/s0003-4975(01)02486-9","journal-title":"Ann Thorac Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.814533","article-title":"Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome","volume":"120","author":"Levin MA","year":"2009","unstructured":"Levin MA, Lin HM, Castillo JG, Adams DH, Reich DL, Fischer GW. Early on-cardiopulmonary bypass hypotension and other factors associated with vasoplegic syndrome. Circulation. 2009, 120:1664-71. 10.1161\/CIRCULATIONAHA.108.814533","journal-title":"Circulation"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivt243","article-title":"Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery","volume":"17","author":"Kortekaas KA","year":"2013","unstructured":"Kortekaas KA, Lindeman JH, Reinders ME, Palmen M, Klautz RJ, de Groot PG, Roest M. Pre-existing endothelial cell activation predicts vasoplegia after mitral valve surgery. Interact Cardiovasc Thorac Surg. 2013, 17:523-30. 10.1093\/icvts\/ivt243","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezw316","article-title":"Incidence and predictors of vasoplegia after heart failure surgery","volume":"51","author":"van Vessem ME","year":"2017","unstructured":"van Vessem ME, Palmen M, Couperus LE, et al.. Incidence and predictors of vasoplegia after heart failure surgery. Eur J Cardiothorac Surg. 2017, 51:532-8. 10.1093\/ejcts\/ezw316","journal-title":"Eur J Cardiothorac Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2019.06.011","article-title":"Vasoplegia after restrictive mitral annuloplasty for functional mitral regurgitation in patients with heart failure","volume":"33","author":"van Vessem ME","year":"2019","unstructured":"van Vessem ME, Petrus AH, Palmen M, Braun J, Schalij MJ, Klautz RJ, Beeres SL. Vasoplegia after restrictive mitral annuloplasty for functional mitral regurgitation in patients with heart failure. J Cardiothorac Vasc Anesth. 2019, 33:3273-80. 10.1053\/j.jvca.2019.06.011","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/aca.aca_54_21","article-title":"VASOplegia is Predicted by Preoperative Platelet\u2010LEucocyte conGlomerate Indices in Cardiac Surgery (VASOPLEGICS): a retrospective single\u2010center study","volume":"25","author":"Magoon R","year":"2022","unstructured":"Magoon R, Kashav RC, Shri I, Dey S, Walian A, Kohli JK. VASOplegia is Predicted by Preoperative Platelet\u2010LEucocyte conGlomerate Indices in Cardiac Surgery (VASOPLEGICS): a retrospective single\u2010center study. Ann Card Anaesth. 2022, 25:414-21. 10.4103\/aca.aca_54_21","journal-title":"Ann Card Anaesth"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2019.12.013","article-title":"Vasoplegia during cardiopulmonary bypass: current literature and rescue therapy options","volume":"34","author":"Ortoleva J","year":"2020","unstructured":"Ortoleva J, Shapeton A, Vanneman M, Dalia AA. Vasoplegia during cardiopulmonary bypass: current literature and rescue therapy options. J Cardiothorac Vasc Anesth. 2020, 34:2766-75. 10.1053\/j.jvca.2019.12.013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2102-1","article-title":"Definitions and pathophysiology of vasoplegic shock","volume":"22","author":"Lambden S","year":"2018","unstructured":"Lambden S, Creagh-Brown BC, Hunt J, Summers C, Forni LG. Definitions and pathophysiology of vasoplegic shock. Crit Care. 2018, 22:174. 10.1186\/s13054-018-2102-1","journal-title":"Crit Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/apha.12646","article-title":"Endothelial dysfunction and vascular disease - a 30th anniversary update","volume":"219","author":"Vanhoutte PM","year":"2017","unstructured":"Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease - a 30th anniversary update. Acta Physiol (Oxf). 2017, 219:22-96. 10.1111\/apha.12646","journal-title":"Acta Physiol (Oxf)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018004","article-title":"Novel blood cytokine-based model for predicting severe acute kidney injury and poor outcomes after cardiac surgery","volume":"9","author":"Chen Z","year":"2020","unstructured":"Chen Z, Chen L, Yao G, Yang W, Yang K, Xiong C. Novel blood cytokine-based model for predicting severe acute kidney injury and poor outcomes after cardiac surgery. J Am Heart Assoc. 2020, 9:e018004. 10.1161\/JAHA.120.018004","journal-title":"J Am Heart Assoc"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2008.12.024","article-title":"Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor","volume":"138","author":"Emani S","year":"2009","unstructured":"Emani S, Ramlawi B, Sodha NR, Li J, Bianchi C, Sellke FW. Increased vascular permeability after cardiopulmonary bypass in patients with diabetes is associated with increased expression of vascular endothelial growth factor and hepatocyte growth factor. J Thorac Cardiovasc Surg. 2009, 138:185-91. 10.1016\/j.jtcvs.2008.12.024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00029.2006","article-title":"Nitric oxide and peroxynitrite in health and disease","volume":"87","author":"Pacher P","year":"2007","unstructured":"Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007, 87:315-424. 10.1152\/physrev.00029.2006","journal-title":"Physiol Rev"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2018.04.007","article-title":"Glycocalyx degradation and inflammation in cardiac surgery","volume":"33","author":"Pesonen E","year":"2019","unstructured":"Pesonen E, Passov A, Andersson S, et al.. Glycocalyx degradation and inflammation in cardiac surgery. J Cardiothorac Vasc Anesth. 2019, 33:341-5. 10.1053\/j.jvca.2018.04.007","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0b013e3182652b7d","article-title":"Complement activation and cardiac surgery: a novel target for improving outcomes","volume":"115","author":"Stahl GL","year":"2012","unstructured":"Stahl GL, Shernan SK, Smith PK, Levy JH. Complement activation and cardiac surgery: a novel target for improving outcomes. Anesth Analg. 2012, 115:759-71. 10.1213\/ANE.0b013e3182652b7d","journal-title":"Anesth Analg"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1727116","article-title":"Thrombin: a pivotal player in hemostasis and beyond","volume":"47","author":"Larsen JB","year":"2021","unstructured":"Larsen JB, Hvas AM. Thrombin: a pivotal player in hemostasis and beyond. Semin Thromb Hemost. 2021, 47:759-74. 10.1055\/s-0041-1727116","journal-title":"Semin Thromb Hemost"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan CN","year":"2018","unstructured":"Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018, 128:2657-69. 10.1172\/JCI97943","journal-title":"J Clin Invest"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5223(03)00969-3","article-title":"Gene expression profile after cardiopulmonary bypass and cardioplegic arrest","volume":"126","author":"Ruel M","year":"2003","unstructured":"Ruel M, Bianchi C, Khan TA, et al.. Gene expression profile after cardiopulmonary bypass and cardioplegic arrest. J Thorac Cardiovasc Surg. 2003, 126:1521-30. 10.1016\/s0022-5223(03)00969-3","journal-title":"J Thorac Cardiovasc Surg"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1111\/aor.14171","article-title":"Narrative review of the systemic inflammatory reaction to cardiac surgery and cardiopulmonary bypass","volume":"46","author":"Squiccimarro E","year":"2022","unstructured":"Squiccimarro E, Stasi A, Lorusso R, Paparella D. Narrative review of the systemic inflammatory reaction to cardiac surgery and cardiopulmonary bypass. Artif Organs. 2022, 46:568-77. 10.1111\/aor.14171","journal-title":"Artif Organs"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001479","article-title":"Effect of perioperative goal-directed hemodynamic resuscitation therapy on outcomes following cardiac surgery: a randomized clinical trial and systematic review","volume":"44","author":"Osawa EA","year":"2016","unstructured":"Osawa EA, Rhodes A, Landoni G, et al.. Effect of perioperative goal-directed hemodynamic resuscitation therapy on outcomes following cardiac surgery: a randomized clinical trial and systematic review. Crit Care Med. 2016, 44:724-33. 10.1097\/CCM.0000000000001479","journal-title":"Crit Care Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2017.10.032","article-title":"Vasoplegia after cardiovascular procedures-pathophysiology and targeted therapy","volume":"32","author":"Shaefi S","year":"2018","unstructured":"Shaefi S, Mittel A, Klick J, Evans A, Ivascu NS, Gutsche J, Augoustides JG. Vasoplegia after cardiovascular procedures-pathophysiology and targeted therapy. J Cardiothorac Vasc Anesth. 2018, 32:1013-22. 10.1053\/j.jvca.2017.10.032","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000287664.03547.c6","article-title":"Online monitoring of pulse pressure variation to guide fluid therapy after cardiac surgery","volume":"106","author":"Auler JO Jr","year":"2008","unstructured":"Auler JO Jr, Galas F, Hajjar L, Santos L, Carvalho T, Michard F. Online monitoring of pulse pressure variation to guide fluid therapy after cardiac surgery. Anesth Analg. 2008, 106:1201-6, table of contents. 10.1213\/01.ane.0000287664.03547.c6","journal-title":"Anesth Analg"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2018.04.006","article-title":"Vasopressin in cardiac surgery: a meta-analysis of randomized controlled trials","volume":"32","author":"D\u00fcnser MW","year":"2018","unstructured":"D\u00fcnser MW, Bouvet O, Knotzer H, Arulkumaran N, Hajjar LA, Ulmer H, Hasibeder WR. Vasopressin in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2018, 32:2225-32. 10.1053\/j.jvca.2018.04.006","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-1967-3","article-title":"Vasoplegia treatments: the past, the present, and the future","volume":"22","author":"Levy B","year":"2018","unstructured":"Levy B, Fritz C, Tahon E, Jacquot A, Auchet T, Kimmoun A. Vasoplegia treatments: the past, the present, and the future. Crit Care. 2018, 22:52. 10.1186\/s13054-018-1967-3","journal-title":"Crit Care"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.14144","article-title":"Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial","volume":"308","author":"Dieleman JM","year":"2012","unstructured":"Dieleman JM, Nierich AP, Rosseel PM, et al.. Intraoperative high-dose dexamethasone for cardiac surgery: a randomized controlled trial. JAMA. 2012, 308:1761-7. 10.1001\/jama.2012.14144","journal-title":"JAMA"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.14797\/mdcvj.1245","article-title":"Vasoplegia: a review","volume":"19","author":"Ratnani I","year":"2023","unstructured":"Ratnani I, Ochani RK, Shaikh A, Jatoi HN. Vasoplegia: a review. Methodist Debakey Cardiovasc J. 2023, 19:38-47. 10.14797\/mdcvj.1245","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1378\/chest.121.3.921","article-title":"Corticosteroids and cardiopulmonary bypass: a review of clinical investigations","volume":"121","author":"Chaney MA","year":"2002","unstructured":"Chaney MA. Corticosteroids and cardiopulmonary bypass: a review of clinical investigations. Chest. 2002, 121:921-31. 10.1378\/chest.121.3.921","journal-title":"Chest"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00273-1","article-title":"Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Whitlock RP","year":"2015","unstructured":"Whitlock RP, Devereaux PJ, Teoh KH, et al.. Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial. Lancet. 2015, 386:1243-53. 10.1016\/S0140-6736(15)00273-1","journal-title":"Lancet"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.24505","article-title":"Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial","volume":"325","author":"Sevransky JE","year":"2021","unstructured":"Sevransky JE, Rothman RE, Hager DN, et al.. Effect of vitamin C, thiamine, and hydrocortisone on ventilator- and vasopressor-free days in patients with sepsis: the VICTAS randomized clinical trial. JAMA. 2021, 325:742-50. 10.1001\/jama.2020.24505","journal-title":"JAMA"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2019.08.034","article-title":"A pilot, double-blind, randomized, controlled trial of high-dose intravenous vitamin C for vasoplegia after cardiac surgery","volume":"34","author":"Yanase F","year":"2020","unstructured":"Yanase F, Bitker L, Hessels L, et al.. A pilot, double-blind, randomized, controlled trial of high-dose intravenous vitamin C for vasoplegia after cardiac surgery. J Cardiothorac Vasc Anesth. 2020, 34:409-16. 10.1053\/j.jvca.2019.08.034","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000001045","article-title":"Methylene blue: magic bullet for vasoplegia?","volume":"122","author":"Hosseinian L","year":"2016","unstructured":"Hosseinian L, Weiner M, Levin MA, Fischer GW. Methylene blue: magic bullet for vasoplegia?. Anesth Analg. 2016, 122:194-201. 10.1213\/ANE.0000000000001045","journal-title":"Anesth Analg"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/s0003-4975(97)00198-7","article-title":"Methylene blue administration in SIRS after cardiac operation","volume":"63","author":"Evora PR","year":"1997","unstructured":"Evora PR, Ribeiro PJ, de Andrade JC. Methylene blue administration in SIRS after cardiac operation. Ann Thorac Surg. 1997, 63:1212-3. 10.1016\/s0003-4975(97)00198-7","journal-title":"Ann Thorac Surg"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.5935\/1678-9741.20140115","article-title":"Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised","volume":"30","author":"Evora PR","year":"2015","unstructured":"Evora PR, Alves Junior L, Ferreira CA, et al.. Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised. Rev Bras Cir Cardiovasc. 2015, 30:84-92. 10.5935\/1678-9741.20140115","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(03)01510-8","article-title":"Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery","volume":"77","author":"Levin RL","year":"2004","unstructured":"Levin RL, Degrange MA, Bruno GF, Mazo CDC, Taborda DJ, Griott JJi, Boullon FJ. Methylene blue reduces mortality and morbidity in vasoplegic patients after cardiac surgery. Ann Thorac Surg. 2004, 77:496-9. 10.1016\/S0003-4975(03)01510-8","journal-title":"Ann Thorac Surg"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.4103\/aca.ACA_237_16","article-title":"Methylene blue for postcardiopulmonary bypass vasoplegic syndrome: a cohort study","volume":"20","author":"Mazzeffi M","year":"2017","unstructured":"Mazzeffi M, Hammer B, Chen E, Caridi-Scheible M, Ramsay J, Paciullo C. Methylene blue for postcardiopulmonary bypass vasoplegic syndrome: a cohort study. Ann Card Anaesth. 2017, 20:178-81. 10.4103\/aca.ACA_237_16","journal-title":"Ann Card Anaesth"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2013.02.026","article-title":"Methylene blue is associated with poor outcomes in vasoplegic shock","volume":"27","author":"Weiner MM","year":"2013","unstructured":"Weiner MM, Lin HM, Danforth D, Rao S, Hosseinian L, Fischer GW. Methylene blue is associated with poor outcomes in vasoplegic shock. J Cardiothorac Vasc Anesth. 2013, 27:1233-8. 10.1053\/j.jvca.2013.02.026","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1213\/01.ane.0000221261.25310.fe","article-title":"The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass","volume":"103","author":"Maslow AD","year":"2006","unstructured":"Maslow AD, Stearns G, Butala P, Schwartz CS, Gough J, Singh AK. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg. 2006, 103:2-8, table of contents. 10.1213\/01.ane.0000221261.25310.fe","journal-title":"Anesth Analg"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.10.038","article-title":"Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery","volume":"79","author":"Ozal E","year":"2005","unstructured":"Ozal E, Kuralay E, Yildirim V, et al.. Preoperative methylene blue administration in patients at high risk for vasoplegic syndrome during cardiac surgery. Ann Thorac Surg. 2005, 79:1615-9. 10.1016\/j.athoracsur.2004.10.038","journal-title":"Ann Thorac Surg"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2017.02.057","article-title":"Methylene blue for vasoplegic syndrome after cardiac operation: early administration improves survival","volume":"104","author":"Mehaffey JH","year":"2017","unstructured":"Mehaffey JH, Johnston LE, Hawkins RB, et al.. Methylene blue for vasoplegic syndrome after cardiac operation: early administration improves survival. Ann Thorac Surg. 2017, 104:36-41. 10.1016\/j.athoracsur.2017.02.057","journal-title":"Ann Thorac Surg"},{"key":"ref49","unstructured":"FDA Drug Safety Communication. serious CNS reactions possible when methylene blue is given to patients taking certain psychiatric medications. (2011). Accessed: September 17, 2024: https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-serious-cns-reactions-possible-w...."},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1177\/2050312120935466","article-title":"Vasoplegia after cardiopulmonary bypass: a narrative review of pathophysiology and emerging targeted therapies","volume":"8","author":"Barnes TJ","year":"2020","unstructured":"Barnes TJ, Hockstein MA, Jabaley CS. Vasoplegia after cardiopulmonary bypass: a narrative review of pathophysiology and emerging targeted therapies. SAGE Open Med. 2020, 8:2050312120935466. 10.1177\/2050312120935466","journal-title":"SAGE Open Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrtlng.2020.11.003","article-title":"Extended duration infusion of high-dose hydroxocobalamin for vasoplegic syndrome following cardiac surgery","volume":"50","author":"Seelhammer TG","year":"2021","unstructured":"Seelhammer TG, Plack D, Nei S, Wittwer E, Nelson J, Nabzdyk CG. Extended duration infusion of high-dose hydroxocobalamin for vasoplegic syndrome following cardiac surgery. Heart Lung. 2021, 50:173-6. 10.1016\/j.hrtlng.2020.11.003","journal-title":"Heart Lung"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2021.05.042","article-title":"Hydroxocobalamin or methylene blue for vasoplegic syndrome in adult cardiothoracic surgery","volume":"36","author":"Kram SJ","year":"2022","unstructured":"Kram SJ, Kram BL, Cook JC, Ohman KL, Ghadimi K. Hydroxocobalamin or methylene blue for vasoplegic syndrome in adult cardiothoracic surgery. J Cardiothorac Vasc Anesth. 2022, 36:469-76. 10.1053\/j.jvca.2021.05.042","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1053\/j.jvca.2018.11.020","article-title":"Methylene blue monotherapy compared with combination therapy with hydroxocobalamin for the treatment of refractory vasoplegic syndrome: a retrospective cohort study","volume":"33","author":"Feih JT","year":"2019","unstructured":"Feih JT, Rinka JR, Zundel MT. Methylene blue monotherapy compared with combination therapy with hydroxocobalamin for the treatment of refractory vasoplegic syndrome: a retrospective cohort study. J Cardiothorac Vasc Anesth. 2019, 33:1301-7. 10.1053\/j.jvca.2018.11.020","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/303242-vasoplegic-syndrome-following-bypass-a-comprehensive-review-of-pathophysiology-and-proposed-treatments","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T11:59:55Z","timestamp":1737979195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/303242-vasoplegic-syndrome-following-bypass-a-comprehensive-review-of-pathophysiology-and-proposed-treatments"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":53,"URL":"https:\/\/doi.org\/10.7759\/cureus.78057","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,27]]}}}